Medtech InsightThe combined market for prostate cancer diagnostics and minimally invasive treatments is set to increase from $900m to $1.46bn in the next five years. But conservative treatment, or watchful waiting,
Medtech InsightThe treatment of cancer has always been a complicated issue. While there are numerous ways available to treat tumors – surgery, radiotherapy and systemic chemotherapy – better detection methods have l
In VivoDevice Transactions Continuing the downward trend in financing over the past several quarters, the device industry collected $1.2 billion in Q2 funding, a 48% decrease from Q1's $2.3 billion total. It
In VivoIN VITRO DIAGNOSTICS Financings Cancer Genetics Inc. Molecular diagnostics firm Cancer Genetics Inc. entered a financing agreement with Aspire Capital, through which Aspire will purchase, over the